PPARA and metabolic dysfunction-associated steatohepatitis: Interestingly, Pawlak and colleagues recently showed that the transrepression activity of PPARα also regulates the inflammatory response in liver, preventing transition from NAFLD to NASH and fibrosis, and occurs independently on PPARα DNA binding activity and its lipid handling properties [100].